Ascorbic Acid and Esketamine for Mental Disorders in Women with Miscarriage: A Randomized Controlled Double-Blind Trial Protocol
Zhaojuan Ke,1 Ying Zhang,1 Binyang Cai,1 Jie Luo,1 Yao Ma,2 Qibin Chen,1 Linya Deng1 1Department of Anesthesiology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People’s Republic of China; 2Department of Geriatrics and National Clinical Research Center for Geriat...
Saved in:
| Main Authors: | Ke Z, Zhang Y, Cai B, Luo J, Ma Y, Chen Q, Deng L |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2025-04-01
|
| Series: | Neuropsychiatric Disease and Treatment |
| Subjects: | |
| Online Access: | https://www.dovepress.com/ascorbic-acid-and-esketamine-for-mental-disorders-in-women-with-miscar-peer-reviewed-fulltext-article-NDT |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Binaural Beat Music and Esketamine for ECT in the Treatment of Major Depressive Disorder: A Randomized Controlled Trial Protocol
by: Zhang Y, et al.
Published: (2025-06-01) -
Ketamine in palliative care: an updated systematic review
by: Kinga Dowierciał, et al.
Published: (2025-07-01) -
Efficacy and safety of ketamine and esketamine in reducing the incidence of postpartum depression: an updated systematic review and meta-analysis
by: Moaz Yasser Darwish, et al.
Published: (2025-02-01) -
Ketamine, Esketamine, and Arketamine: Their Mechanisms of Action and Applications in the Treatment of Depression and Alleviation of Depressive Symptoms
by: Piotr Kawczak, et al.
Published: (2024-10-01) -
Adjunctive ketamine vs. buprenorphine in co-occurring major depressive disorder and opioid use disorder: a randomized, double-blind clinical trial assessing anxiety symptom severity and craving intensity
by: Arash Mansoori, et al.
Published: (2025-04-01)